To compare the efficacy and safety of new insulin glargine @ units/mL ( Gla-@ ) with glargine @ units/mL ( Gla-@ ) in people with type @ diabetes using basal insulin ( @ units/day ) plus oral antihyperglycemic drugs ( OADs ) .